Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

 
   Single User - $4,500
   Site License (one location, 10 users) - $6,750
   Corporate License - $9,000



Loading...
Published Aug 8, 2018 | 264 Pages | Pub ID: KLI15732352

Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

The global market for human vaccines is experiencing strong growth, fuelled by favorable demographics (population growth, rising life expectancy), continued new product introductions, indication expansions for some products and rising usage, particularly in India and China. Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments examines the market for vaccines used in humans to prevent various types of disease, providing a comprehensive market summary.

Total World Vaccine Market

While vaccines account for only a small portion of the world pharmaceutical market, their growth will continue to strongly outpace that of broader drug market. The report provides a comprehensive world market summary, including:
  • Total World Market for Preventive Vaccines by Type, 2015–2024 (Pediatric Total: Combinations, Hepatitis, HIB, MMR, Pneumococcal, Poliovirus, Varicella, Others; Adult Total: Cervical, Hepatitis, Influenza, Pneumococcal, Travel & Other; Total)
  • Total World Market for Vaccines by Type, 2015-2024 (Pediatric, Adult)
  • World Market for Vaccines Share by Type, 2015 (Pediatric, Adult) (%)
  • World Market for Vaccines Share by Type, 2024 (Pediatric, Adult) (%)
Pediatric Preventative Vaccine Market

The major vaccine-preventable diseases that disproportionately affect children are discussed in the report, along with current products and key products under development. Among the global as well as disease-specific and regional sales data of the pediatric vaccine market presented include the following:
  • World Market for Pediatric Preventive Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) 2015–2024
  • Market Share of Pediatric Preventative Vaccines by Type, 2017 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
  • Market Share of Pediatric Preventative Vaccines by Type, 2024 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
  • World Market for Pediatric Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024
  • World Pediatric Hepatitis Vaccine Market, 2015-2024
  • World Haemophilus Influenzae Type B (Hib) Vaccine Market, 2015-2024
  • World Measles, Mumps and Rubella (MMR) Vaccine Market, 2015-2024
  • World Pediatric Combination Vaccine Market, 2015-2024
  • World Pediatric Pneumococcal Vaccine Market, 2015-2024
  • World Poliovirus Vaccine Market, 2015-2024
  • World Pediatric Varicella Vaccine Market, 2015-2024
  • World Other Pediatric Vaccine Market, 2015-2024
Adult Preventative Vaccine Market

The major vaccine-preventable diseases that mainly affect adults are discussed in the report, along with current products and key products under development. Among the global as well as disease-specific and regional sales data of the adult vaccine market presented include the following:
  • World Market Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/Other) 2015–2024
  • Market Share of Adult Preventative Vaccines by Type, 2017 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
  • Market Share of Adult Preventative by Type, 2024 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
  • World Market for Adult Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015–2024
  • World Cervical Cancer Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Hepatitis Preventative Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Influenza Preventative Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Pneumococcal Preventative Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Travel and Other Preventative Vaccine Market, 2015-2024 ($ Millions)
Issues and Trends in the Market

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues are impacting the vaccines industry both positively and negatively. Vaccines 2018 discusses some of the most important macro and micro trends, including:
  • Rising life expectancy;
  • increasing obesity;
  • growing out of pocket spending on healthcare;
  • health insurance changes in the U.S.;
  • decentralization of healthcare services;
  • austerity programs in Europe;
  • global healthcare mergers and acquisitions;
  • vaccine safety challenges and negative public opinion;
  • vaccine shortages;
  • refusal to vaccinate.
Competitive Landscape

The report also discusses the vaccine businesses of industry leaders as well as emerging players with high potential. Many of the larger companies – some active in other areas in addition to vaccines – are discussed, with a focus on their preventative vaccine businesses and products. (Specifically excluded is discussion of related infectious disease products such as therapeutic vaccines and monoclonal antibodies.) An effort has been made to provide the most significant new developments of the important players in the industry, including:
  • Bavarian Nordic A/S
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • CSL Limited
  • Daiichi Sankyo Co. Ltd.
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hawaii Biotech
  • Medimmune
  • Merck & Co. Inc.
  • Mymetics
  • PaxVax
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Soligenix
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.